Deep are younger than a dairy. President trump has been complaining that the election stinks to high heaven and he has had it stolen from him, including the great state of michigan, both being greater than the number of people that voted, the democrats cheated bigtime and got caught, a republican win and they would not let republicans or poll watchers into the counting room, unconstitutional. And sometimes my favorite, i won the election. Today we have the White House Press secretary echoing those sentiments and once that there was three types of ballots that were found in georgia, amounting to nearly 6000 votes, we have 234 pages of sworn affidavits in michigan and one county alone, alleging egregious misconduct by those pushing back the observers on allegations of fraud,. The officials in all 50 states say that no results are legit, the department of Homeland Security said the election was the most secure in u. S. History. So what about the crooked election theories persist in . How
Both the book i cant breathe or older titles by the authors. When you buy the book to get the literary experience but also your independent bookstores can bring your events like this that we appreciate that in the dance. Flyers for Upcoming Events available with great step in november so we hope youll join us again. Our interviewer for this weekend is through may and hosted a Television Show binge worthy as well as a new podcast love city. He writes for rolling dont come the New York Times committed new yorker and many other publications and is the author of five books including most recently i would die for you at prince became an icon in his afraid to post blackness, what it means to be back now. Also our neighbor and a great supporter greatness is literally the day we opened our doors of a grateful to have them here with us tonight. So this chick with dr. Matt taibbi of the New York Times bestselling think on president , for still be in the great arrangement could also contribute an
Play. I want to thank allen and pew for hosting this meeting, for organizing the publishing of the special supplement and of course to mr. Gottlieb for his remarks at the beginning of the day. So the focus of this final panel today is the fact that in certain high profile cases manufacturers have released incorrect or incomplete information into the market that was directly counter to the information, the contemporaneous information the fda had. They noted that selective publication of Clinical Trial results has in the past created a misleading picture of the safety and efficacy of a product with negative implications for Public Health. And as a the practice now still stands, manufactures have wide latitude to publicly characterize data that were submitted to the fda without much risk that the fda will correct the record. I think were going to try to talk a little bit about in the next hour is, you know, in these cases does the fda have a Public Health or an ethical responsibility to c
[ is distinct conversations ]. And live here this morning on c spann span 3, a discussion about transparency and oversight at the food and Drug Administration. Well be hearing from dr. Scott gottlieb starting off the conference. Introductions under way. Efforts to pass and implement the food safety modernization act, focus on medical devices, especially the potential of using the unique device identifier to improve monitoring devices throughout the product lifecycle. We have successfully worked on products 10 to courage innovation particularly around antibiotics and 10 to sure appropriate use of them. We focused on drug safety and transparency in the supply chain and especially on the safety of compounded drugs. Among other things, pew submitted transparency to the task force back in 2010 if the. They touch on some of the topics well be discussing today. Reading the background papers for todays meet regular mind med of a meeting we convened in a room directly above of us here a few yea
Thank you very much, josh, for that very nice introduction. I am aaron khere to introduce te final panel of the day that relates to another important set of Public Health functions, that Greater Transparency about information and regulatory decisions about the fda can play. I want to thank allen and pew for hosting this meeting, for organizing the publishing of the special supplement and of course to mr. Gottlieb for his remarks at the beginning of the day. So the focus of this final panel today is the fact that in certain high profile cases manufacturers have released incorrect or incomplete information into the market that was directly counter to the information, the contemporaneous information the fda had. They noted that selective publication of Clinical Trial results has in the past created a misleading picture of the safety and efficacy of a product with negative implications for Public Health. And as a the practice now still stands, manufactures have wide latitude to publicly ch